CD19 CAR T Cells Persist Beyond a Decade
A peer-reviewed Nature Medicine study from the University of Pennsylvania characterized 4-1BB-costimulated CD19 CAR T cells up to 10.1 years after infusion in 38 patients with B-cell non-Hodgkin lymphoma. Beyond year five, the CAR…
